|
| | | | | | | | |
| Small Products | | | | | | | |
| Accolate | | | | | | | |
| Oxis | | | | | | | |
| Faslodex | | | | | | | |
| Vimovo (PN400) | Acid Reflux | POZN | 4/30/2010 | Naproxen+Nexium | Generics | Oral | Composition |
| Abraxane | Metastatic Breast Cancer | ABBI | | Taxane | | | |
| NKTR-118/119 | OIC | returned to NKTR? | III | Opioid antagonist | | | |
| Toprol XL/Seloken?? | Hypertension | | | | Oral | | |
| | | | | | | | |
| Atacand (candesartan) | Hypertension | | | | Oral | | |
| Nexium (esomeprazole) | Acid Reflux | 1 | | PPI | Oral | | |
| Crestor (rosuvastatin) | Lipid Lowering | Shionogi | 8/12/2003 | Statin | Oral | | |
| Seroquel (quetiapine) | Schizophrenia | 1 | 5/17/2007 | Atypical | Oral | | |
| Seroquel SR (quetiapine) | Schizophrenia | 1 | 9/26/1997 | Atypical | Oral | | |
| Arimidex (anastrozole) | Breast Cancer | 100%? | | Aromatase | Oral | | |
| Zoladex | Cancer | | | | | | |
| Casodex | Cancer | | | | | | |
| Axanum (ASA+Nexium) | | | | | | | |
| Ceftaroline | cSSSI | FRX | III | Beta-lactamase | | | |
| | | | | | | | |
| Failures | | | | | | | |
| ximelagatran, fka Exanta/Exarta | anticoagulant | | | | | | |
| AZD9684 | | | | | | | |
| AZD4054 | HRPC | | | | | | |
| AZD9056 | | | | | | | |
| AZD8955 | | | | | | | |
| AZD5896 | | | | | | | |
| AZD1480 | MPN | JAK2 | | | | | |
| AZD1279 | | | | | | | |
| AZD0530 | | | | | | | |
| AZD1940 | | | | | | | |
| AZD4121 | Hypercholesterolemia | | | | | | |
| MEDI-561 | | | | | | | |
| AZD3342 | | | | | | | |
| AZD0328 | | | | | | | |
| AZD2479 | | | | | | | |
| AZD6610 | | | | | | | |
| Movatizumab/Numax | | | | | | | |
| AZD7009 | | | | | | | |
| Exanta | | | | | | | |
| AZD5180 | | | | | | | |
| AZD2043 | | | | | | | |
| AZD3480 | Alzheimer's | TRGT | | | | | |
| ADD0837 (atecegatran) | anticoagulant | | | | | | |
| zibotenan | | | | | | | |
| Certriad | | | | | | | |
| TC-5214 | | | | | | | |
| CEO David Brennan (2006-2012) | | | | | | | |
| AZD1656 | | | | | | | |
| AZD6714 | | | | | | | |
| AZD2066 | | | | | | | |
| AZD3043 | | | | | | | |
| TC-5619 | | | | | | | |
| R788 (fostamatinib) | RA | Returned to RIGL | III | Syk | Oral | NCE | |
| AZD-1152 | | | | | | | |
| MEDI-528 | | | | | | | |
| cedarinib | | | | | | | |
| Zactima (vandetanib) | MTC, NSCLC | 1 | Filed | Kinase Inhibitor | Oral | | |
| TC-1473 | Cognitive | TRGT | II | Old | Oral | | |
| 3480 | ADHD | TRGT | II | Alpha4/Beta2 | Oral | | |
| 8529 | Schizophrenia | 1 | II | Glutamatergic | | | |
| 7295 | Hepatitis C | 1 | II | NS5A | | | |
| MEDI-573 | Cancer | 1 | I | IGFR | | | |
| CytoFab | Severe Sepsis | BTG, fka Protherics | | polyclonal anti-TNF-alpha antibody fragment | | | |
| 6765 | Depression | 1 | II | NMDA | | | |
| 2327 | Anxiety/Depression | 1 | II | Enkephalinergic | | | |
| 7268 | Anxiety/Depression | 1 | II | Enkephalinergic | | | |
| 2066 | Pain | 1 | II | mGlu5 antagonist | | | |
| 3355 (lesogaberan) | GERD | 1 | II | GABAB | | | |
| 6370 | Diabetes | 1 | II | GK Activator | | | |
| 6482 | Thrombosis | 1 | I | PI3K-beta | | | |
| 4017 | Diabetes | 1 | I | 11BHSD | | | |
| 8329 | Diabetes | 1 | I | 11BHSD | | | |
| 7687 | Diabetes | 1 | I | DAT-1 | | | |
| 1386 | GERD | 1 | II | Vanilloid | | | |
| 2516 | GERD | 1 | I | mGlu5 antagonist | | | |
| AZD7009 - Afib | | | | | | | |
| Cerovive - Stroke | | | | | | | |
| AGI-1067 - Atherosclerosis | | | | | | | |